Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
| Applications | ELISA, IHC |
| Reactivities | Human |
Recombinant Anti-Fas (Clone R-125224)
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-RSV (Clone RSHZ19 (Felvizumab))
| Applications | ELISA, FN |
| Reactivities | Respiratory Syncytial Virus |
Recombinant Anti-CD64 (Clone H22)
| Applications | CT, FC |
| Reactivities | Human |
Recombinant Anti-PD-L1 (Clone 332M7)
| Applications | Bl, FC |
| Reactivities | Human, Mouse, Monkey |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
| Applications | ELISA, IF |
| Reactivities | SARS-CoV |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
| Applications | ELISA, IF |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
| Applications | FC, IF |
| Reactivities | Human |